Literature DB >> 9869320

Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria.

H Braak1, E Braak.   

Abstract

Argyrophilic grain disease is a progressive degenerative disorder of the human brain which becomes increasingly prevalent with advancing age. The disease entails multiple neuronal systems and results from cytoskeletal degeneration in only a few neuronal types and in oligodendrocytes. Immunoreactions for abnormally phosphorylated tau protein permit identification of the changes. Only a fraction of the emerging abnormal fibrillary material shows a pronounced argyrophilia. Essential for neuropathological diagnosis is assessment of the presence of small spindle-shaped argyrophilic grains in neuronal processes. The anteromedial portion of the temporal lobe bears the brunt of the lesions. Grains generally can be found in abundance in the entorhinal region, the first Ammon's horn sector, the subcortical nuclear complex of the amygdala, and the hypothalamic lateral tuberal nucleus. Frequently, the lesions co-exist with those typically found in Alzheimer's disease or other tauopathies. Owing to the characteristic grains, the disorder easily can be differentiated from other tauopathies. 2661 non-selected brains obtained at autopsy included 125 cases of argyrophilic grain disease (5%) from individuals between 51 and 96 years of age (mean 79 years) . The fact that the same material contained 146 cases of fully developed Alzheimer's disease (6%) supports the view that argyrophilic grain disease is not a rare disorder. Its prevalence with and without concomitant neurofibrillary changes of the Alzheimer type grows with increasing age. Argyrophilic grain disease merits attention because of its frequent occurrence and its potential to cause severe brain dysfunction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9869320     DOI: 10.1007/s007020050096

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  40 in total

1.  A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease.

Authors:  Richard A Armstrong; Paul T Kotzbauer; Joel S Perlmutter; Meghan C Campbell; Kyle M Hurth; Robert E Schmidt; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2013-08-31       Impact factor: 3.575

2.  Translational gene mapping of cognitive decline.

Authors:  Beth Wilmot; Shannon K McWeeney; Randal R Nixon; Thomas J Montine; Jamie Laut; Christina A Harrington; Jeffrey A Kaye; Patricia L Kramer
Journal:  Neurobiol Aging       Date:  2006-12-14       Impact factor: 4.673

Review 3.  Primary Age-Related Tauopathy (PART): Addressing the Spectrum of Neuronal Tauopathic Changes in the Aging Brain.

Authors:  Richard A Hickman; Xena E Flowers; Thomas Wisniewski
Journal:  Curr Neurol Neurosci Rep       Date:  2020-07-14       Impact factor: 5.081

4.  The Framingham Brain Donation Program: neuropathology along the cognitive continuum.

Authors:  Rhoda Au; Sudha Seshadri; Kristen Knox; Alexa Beiser; Jayandra J Himali; Howard J Cabral; Sanford Auerbach; Robert C Green; Philip A Wolf; Ann C McKee
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

Review 5.  The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer's disease.

Authors:  Carolyn C Rudy; Holly C Hunsberger; Daniel S Weitzner; Miranda N Reed
Journal:  Aging Dis       Date:  2015-03-10       Impact factor: 6.745

6.  The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.

Authors:  Rik Ossenkoppele; Yolande A L Pijnenburg; David C Perry; Brendan I Cohn-Sheehy; Nienke M E Scheltens; Jacob W Vogel; Joel H Kramer; Annelies E van der Vlies; Renaud La Joie; Howard J Rosen; Wiesje M van der Flier; Lea T Grinberg; Annemieke J Rozemuller; Eric J Huang; Bart N M van Berckel; Bruce L Miller; Frederik Barkhof; William J Jagust; Philip Scheltens; William W Seeley; Gil D Rabinovici
Journal:  Brain       Date:  2015-07-02       Impact factor: 13.501

7.  Prominent psychiatric symptoms in patients with Parkinson's disease and concomitant argyrophilic grain disease.

Authors:  O Grau-Rivera; E Gelpi; M J Rey; F Valldeoriola; E Tolosa; Y Compta; M J Martí
Journal:  J Neurol       Date:  2013-09-18       Impact factor: 4.849

Review 8.  Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-Related Tauopathy.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Continuum (Minneap Minn)       Date:  2019-02

9.  Brain injury biomarkers are not dependent on β-amyloid in normal elderly.

Authors:  David S Knopman; Clifford R Jack; Heather J Wiste; Stephen D Weigand; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Rosebud O Roberts; Bradley F Boeve; Ronald C Petersen
Journal:  Ann Neurol       Date:  2013-02-19       Impact factor: 10.422

10.  Oligomers of the amyloid-beta protein disrupt working memory: confirmation with two behavioral procedures.

Authors:  Alan Poling; Kineta Morgan-Paisley; John J Panos; Eun-Mee Kim; Eugene O'Hare; James P Cleary; Sylvain Lesné; Karen H Ashe; Matthew Porritt; Lisa E Baker
Journal:  Behav Brain Res       Date:  2008-06-08       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.